Skolarus, Ted AHawley, Sarah TForman, JaneSales, Anne ESparks, Jordan BMetreger, TabithaBurns, JenniferCaram, Megan VRadhakrishnan, ArchanaDossett, Lesly AMakarov, Danil VLeppert, John TShelton, Jeremy BStensland, Kristian DDunsmore, JenniferMaclennan, StevenSaini, SameerHollenbeck, Brent KShahinian, VahaknWittmann, Daniela ADeolankar, VaradSriram, S2024-07-232024-07-232024-04-09Skolarus, T A, Hawley, S T, Forman, J, Sales, A E, Sparks, J B, Metreger, T, Burns, J, Caram, M V, Radhakrishnan, A, Dossett, L A, Makarov, D V, Leppert, J T, Shelton, J B, Stensland, K D, Dunsmore, J, Maclennan, S, Saini, S, Hollenbeck, B K, Shahinian, V, Wittmann, D A, Deolankar, V & Sriram, S 2024, 'Unpacking overuse of androgen deprivation therapy for prostate cancer to inform de-implementation strategies', Implementation Science Communications, vol. 5, 37. https://doi.org/10.1186/s43058-024-00576-x2662-2211PubMedCentral: PMC11005280ORCID: /0000-0002-2691-8421/work/164505920ORCID: /0000-0002-6892-0247/work/195320663https://hdl.handle.net/2164/23890131477490engSDG 3 - Good Health and Well-beingR Medicine (General)R1Unpacking overuse of androgen deprivation therapy for prostate cancer to inform de-implementation strategiesJournal article10.1186/s43058-024-00576-x